Market Cap ₹45 Cr.
Stock P/E
P/B 2.1
Current Price ₹32.4
Book Value ₹ 15.1
Face Value 10
52W High ₹56
Dividend Yield 0%
52W Low ₹ 11.8
Valencia Nutrition Ltd, an applied biotechnology organisation, develops, manufactures, distributes, and sells multi-nutrient functional drinks to prevent and/or manage lifestyle associated sicknesses. It offers low-calorie functional beverages in a variety of flavours below the Bounce and VitaMe brand names. Valencia Nutrition Ltd was incorporated in 2013 and is based in Mumbai, India.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) |
---|
Net Sales |
Other Income |
Total Income |
Total Expenditure |
Operating Profit |
Interest |
Depreciation |
Exceptional Income / Expenses |
Profit Before Tax |
Provision for Tax |
Profit After Tax |
Adjustments |
Profit After Adjustments |
Adjusted Earnings Per Share |
#(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|
Net Sales | 1 | 0 | 1 | 2 | 1 | 0 | 1 | |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Total Income | 1 | 0 | 1 | 2 | 1 | 0 | 1 | |
Total Expenditure | 2 | 2 | 4 | 7 | 4 | 1 | 3 | |
Operating Profit | -1 | -1 | -2 | -4 | -3 | -1 | -1 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | -0 | 0 | 0 | |
Profit Before Tax | -1 | -1 | -2 | -4 | -4 | -1 | -1 | |
Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Profit After Tax | -1 | -1 | -2 | -4 | -4 | -1 | -1 | |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Profit After Adjustments | -1 | -1 | -2 | -4 | -4 | -1 | -1 | |
Adjusted Earnings Per Share | -3.3 | -2 | -3.4 | -4.4 | -3.6 | -0.7 | -1.3 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 0% | -21% | 0% | 0% |
Operating Profit CAGR | 0% | 0% | 0% | 0% |
PAT CAGR | 0% | 0% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 121% | 55% | NA% | NA% |
ROE Average | 0% | -63% | -118% | -458% |
ROCE Average | -93% | -77% | -114% | -107% |
#(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|
Shareholder's Funds | -1 | 1 | 1 | 5 | 1 | 1 | -1 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 1 | 0 | 0 | 1 | 0 | 1 | 2 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 0 | 0 | 1 | 1 | 2 | 1 | 1 |
Total Liabilities | 0 | 2 | 1 | 7 | 4 | 2 | 3 |
Fixed Assets | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
Total Current Assets | 0 | 1 | 1 | 5 | 2 | 2 | 3 |
Total Assets | 0 | 2 | 1 | 7 | 4 | 2 | 3 |
#(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 0 | 1 | 0 | 3 | 0 | 0 |
Cash Flow from Operating Activities | -1 | -1 | -3 | -4 | -2 | -1 | -2 |
Cash Flow from Investing Activities | -0 | -0 | -0 | -2 | -0 | 1 | 0 |
Cash Flow from Financing Activities | 1 | 2 | 2 | 9 | -0 | 0 | 2 |
Net Cash Inflow / Outflow | -0 | 1 | -1 | 3 | -3 | -0 | 0 |
Closing Cash & Cash Equivalent | 0 | 1 | 0 | 3 | 0 | 0 | 0 |
# | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | -3.28 | -2.02 | -3.35 | -4.37 | -3.6 | -0.67 | -1.27 |
CEPS(Rs) | -3.18 | -1.92 | -3.25 | -4.24 | -3.47 | -0.59 | -1.2 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | -2.3 | 1.94 | 1.02 | 4.87 | 1.27 | 0.6 | -0.67 |
Core EBITDA Margin(%) | -195 | -265.43 | -152.13 | -176.46 | -310.18 | 0 | -81.38 |
EBIT Margin(%) | -200.14 | -275.99 | -151.17 | -181 | -365.12 | 0 | -86.42 |
Pre Tax Margin(%) | -200.14 | -280.94 | -151.17 | -182.78 | -374.58 | 0 | -86.46 |
PAT Margin (%) | -200.14 | -280.94 | -151.17 | -182.78 | -374.58 | 0 | -86.46 |
Cash Profit Margin (%) | -194.3 | -267.3 | -146.61 | -177.61 | -360.51 | 0 | -81.42 |
ROA(%) | -446.65 | -119.45 | -141.52 | -105.42 | -68.12 | -21.58 | -48.28 |
ROE(%) | 0 | -2617.83 | -242.29 | -158.04 | -117.39 | -71.34 | 0 |
ROCE(%) | 0 | -180.57 | -201.22 | -136.02 | -95.47 | -43.4 | -93.18 |
Receivable days | 39.34 | 42.04 | 19.09 | 12.03 | 8.88 | 0 | 43.74 |
Inventory Days | 51.16 | 112.07 | 67.5 | 100.08 | 192.31 | 0 | 114.17 |
Payable days | 134.24 | 131.05 | 46.85 | 36.94 | 97.81 | 0 | 63.75 |
PER(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Price/Book(x) | 0 | 0 | 0 | 5.31 | 8.43 | 13.85 | -18.36 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 1.61 | -1.74 | 0.14 | 9.84 | 11.42 | 0 | 9.82 |
EV/Core EBITDA(x) | -0.83 | 0.66 | -0.1 | -5.6 | -3.79 | -15.13 | -12.06 |
Net Sales Growth(%) | 0 | -43.61 | 243.16 | 67.48 | -59.76 | -100 | 0 |
EBIT Growth(%) | 0 | 22.23 | -87.96 | -100.54 | 18.82 | 81.22 | -92.81 |
PAT Growth(%) | 0 | 20.84 | -84.65 | -102.51 | 17.53 | 81.5 | -90.84 |
EPS Growth(%) | 0 | 38.37 | -65.94 | -30.28 | 17.53 | 81.5 | -90.84 |
Debt/Equity(x) | -0.97 | 0.16 | 0.28 | 0.13 | 0.45 | 1 | -3.27 |
Current Ratio(x) | 0.58 | 5.38 | 2.26 | 3.45 | 0.99 | 1.72 | 2.01 |
Quick Ratio(x) | 0.28 | 4.83 | 1.55 | 2.75 | 0.95 | 1.66 | 1.35 |
Interest Cover(x) | 0 | -55.85 | 0 | -101.62 | -38.6 | -93.53 | -2524.6 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0.03 | 0.05 | 0.07 | 0.18 |
# | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 63.88 | 63.88 | 63.88 | 63.88 | 63.88 | 63.88 | 63.88 | 63.88 | 63.88 | 65.49 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 36.12 | 36.12 | 36.12 | 36.12 | 36.12 | 36.12 | 36.12 | 36.12 | 36.12 | 34.51 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.37 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.19 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 0.56 | 0.56 | 0.56 | 0.56 | 0.56 | 0.56 | 0.56 | 0.56 | 0.56 | 0.56 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About